Kenzo Kudo

905 total citations
67 papers, 724 citations indexed

About

Kenzo Kudo is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kenzo Kudo has authored 67 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Pharmacology and 11 papers in Oncology. Recurrent topics in Kenzo Kudo's work include Pharmacy and Medical Practices (8 papers), Ginseng Biological Effects and Applications (6 papers) and Chemotherapy-related skin toxicity (6 papers). Kenzo Kudo is often cited by papers focused on Pharmacy and Medical Practices (8 papers), Ginseng Biological Effects and Applications (6 papers) and Chemotherapy-related skin toxicity (6 papers). Kenzo Kudo collaborates with scholars based in Japan, United States and New Zealand. Kenzo Kudo's co-authors include Eiichi Tachikawa, Takeshi Kashimoto, Eiji Takahashi, Takeshi Chiba, Junya Sato, Kazuho Harada, Jun Terashima, Shogo Ozawa, Wataru Habano and Atsushi Sanbe and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Endocrinology.

In The Last Decade

Kenzo Kudo

63 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenzo Kudo Japan 16 343 143 117 75 66 67 724
Jin‐Moo Lee South Korea 15 214 0.6× 95 0.7× 79 0.7× 108 1.4× 68 1.0× 62 792
Jayasree Basivireddy India 16 238 0.7× 134 0.9× 78 0.7× 98 1.3× 48 0.7× 19 863
Xiaohui Yu China 16 295 0.9× 60 0.4× 87 0.7× 92 1.2× 45 0.7× 37 734
Mansour A. Alghamdi Saudi Arabia 15 253 0.7× 94 0.7× 109 0.9× 37 0.5× 22 0.3× 100 753
Rui Shi China 18 382 1.1× 93 0.7× 90 0.8× 44 0.6× 103 1.6× 59 855
Nobuaki Matsui Japan 20 234 0.7× 115 0.8× 99 0.8× 104 1.4× 53 0.8× 50 945
Min‐Jung Kim South Korea 18 185 0.5× 42 0.3× 76 0.6× 84 1.1× 64 1.0× 67 724
Aizhong Wang China 14 228 0.7× 75 0.5× 39 0.3× 42 0.6× 72 1.1× 46 699
Zhen Zhan China 17 353 1.0× 77 0.5× 138 1.2× 56 0.7× 139 2.1× 43 868

Countries citing papers authored by Kenzo Kudo

Since Specialization
Citations

This map shows the geographic impact of Kenzo Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenzo Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenzo Kudo more than expected).

Fields of papers citing papers by Kenzo Kudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenzo Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenzo Kudo. The network helps show where Kenzo Kudo may publish in the future.

Co-authorship network of co-authors of Kenzo Kudo

This figure shows the co-authorship network connecting the top 25 collaborators of Kenzo Kudo. A scholar is included among the top collaborators of Kenzo Kudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenzo Kudo. Kenzo Kudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Asahi, Koichi, et al.. (2023). Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer. Cancer Chemotherapy and Pharmacology. 91(5). 427–434. 3 indexed citations
4.
Saito, Yoko, et al.. (2023). Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study. Cancer Chemotherapy and Pharmacology. 93(4). 319–328.
5.
Asaka, Junichi, et al.. (2023). Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone. Supportive Care in Cancer. 31(4). 208–208. 2 indexed citations
6.
Saito, Yoko, et al.. (2022). Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study. Journal of Pharmaceutical Health Care and Sciences. 8(1). 22–22. 1 indexed citations
7.
Asaka, Junichi, et al.. (2021). Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In Vitro. International Journal of Nephrology. 2021. 1–8. 5 indexed citations
8.
Asaka, Junichi, et al.. (2021). Analysis of risk factors for skin disorders caused by anti‐epidermal growth factor receptor antibody drugs and examination of methods for their avoidance. Journal of Clinical Pharmacy and Therapeutics. 46(5). 1404–1411. 4 indexed citations
9.
Maeda, Tomoji, et al.. (2020). Physiologic changes in serotonin concentrations in breast milk during lactation. Nutrition. 79-80. 110969–110969. 4 indexed citations
10.
Sato, Junya, et al.. (2018). The efficacy of sodium azulene sulfonate L-glutamine for managing chemotherapy-induced oral mucositis in cancer patients: a prospective comparative study. Journal of Pharmaceutical Health Care and Sciences. 4(1). 20–20. 19 indexed citations
11.
Sato, Junya, et al.. (2017). Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study. Journal of Pharmaceutical Health Care and Sciences. 3(1). 21–21. 11 indexed citations
12.
Sato, Junya, et al.. (2017). Case series on the association between blood levels and side effects of afatinib maleate. Cancer Chemotherapy and Pharmacology. 80(3). 545–553. 5 indexed citations
13.
Terashima, Jun, et al.. (2016). VEGF expression is regulated by HIF‐1α and ARNT in 3D KYSE‐70, esophageal cancer cell spheroids. Cell Biology International. 40(11). 1187–1194. 17 indexed citations
14.
Chiba, Takeshi, Tomoji Maeda, Atsushi Sanbe, & Kenzo Kudo. (2016). Serotonin suppresses β-casein expression via PTP1B activation in human mammary epithelial cells. Biochemical and Biophysical Research Communications. 473(1). 323–328. 13 indexed citations
15.
Terashima, Jun, et al.. (2015). CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures. Drug Metabolism and Pharmacokinetics. 30(6). 434–440. 30 indexed citations
16.
Terashima, Jun, et al.. (2013). An aryl hydrocarbon receptor induces VEGF expression through ATF4 under glucose deprivation in HepG2. BMC Molecular Biology. 14(1). 27–27. 38 indexed citations
17.
Chiba, Takeshi, et al.. (2012). Effect of nutritional status on transdermal fentanyl absorption in cancer patients. Palliative Care Research. 7(2). 395–402. 3 indexed citations
18.
Tachikawa, Eiichi, et al.. (2009). Inflammatory cytokines decrease the expression of nicotinic acetylcholine receptor during the cell maturation. Molecular and Cellular Biochemistry. 333(1-2). 57–64. 15 indexed citations
19.
Tachikawa, Eiichi, et al.. (2001). Characterization of the functional subunit combination of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells. Neuroscience Letters. 312(3). 161–164. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026